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ABSTRACT 
Objective: With their new and efficacious active ingredients, patented drugs have important roles in offering high-quality healthcare. However, 
huge cost-related barriers in accessing patented drugs along with the availability of low-cost bioequivalent generics have great impact on drugs 
policy in Vietnam. To understand situation of patented drugs utilization at hospitals for a certain period, this pilot study was conducted at Nguyen-
Dinh-Chieu Hospital in Ben-Tre Province. 
Methods: The cross-sectional descriptive study was conducted on the retrospective data of all patented drugs used at Nguyen-Dinh-Chieu Hospital 
in Ben-Tre Province from 2011-2017. Characteristics of drugs utilization were described by frequency and percentage of drugs quantities and costs. 
Criteria for the description were as follows: active ingredient, route of administration, therapeutic class and manufacturing country. Data were 
extracted from the hospital information system and were processed by R software. 
Nguyen Dinh Chieu 
Hospital, Ben Tre Province, Vietnam 
Email: hoangthynhacvu@upm.edu.vn 
Results: From 2011 to 2017, there were 212 patented drugs used which related to 145 active ingredients and 20 therapeutic classes. 88% were 
single active ingredient drugs and 49% were oral drugs. Antimicrobial and cardiovascular drugs represented the largest number of drugs and the 
highest cost. 79% of patented drugs were manufactured by companies in Europe and the majority came from France and Germany. 
Conclusion: This study provided initial information about the utilization of patented drugs during a long period of time at a Vietnamese hospital. 
The understanding gained will aid medical managers in assessment and adjustment of the drugs list, thus, optimizing the hospital budget and the 
equity in access to drugs within communities. 
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Drug utilization research is crucial to ensure an accurate supply of 
appropriate drugs at hospitals [1-2]. Of particular concern in this field is 
studying the utilization of patented drugs in healthcare and treatment 
practices. Although patented drugs offer new and efficacious active 
ingredients, purchasing and using them in hospitals presents some 
challenges. In Vietnam, due to the huge cost disadvantage of patented 
drugs, their lower-cost bioequivalent generics are recommended as 
replacements as stated in the Health Ministry's drugs policy [3-4]. In fact, 
the proportion of the budget to purchase patented drugs, which is 
regulated by the Health Ministry, depends on the hospital levels [5]. As of 
June 2018, lists of off-patent and off-exclusivity drugs and their approved 
generics have not been announced by the Vietnam Ministry of Health. 
Consequently, these off-patent and off-exclusivity drugs still won the 
high bid prices which had a great impact on the drugs budget of hospitals 
and the affordability for drugs of communities. Additionally, according to 
regulations on drug registration, each patented drug obtains a 
registration number for circulation which expires every 5 y [6]. 
Therefore, the lists of patented drugs in hospitals vary regarding both 
types and quantity every year. 
Nguyen-Dinh-Chieu Hospital, which has 1,100 beds, is the largest 
general hospital in Ben-Tre Province and all medical examination 
and treatment costs are reimbursed by Health Insurance Funding. As 
of 2018, the hospital is officially recognized as one of the first level 
hospitals in Vietnam. The study was conducted to discover main 
characteristics of patented drugs utilization at Nguyen-Dinh-Chieu 
Hospital during the 7 y period. 
MATERIALS AND METHODS 
Study design 
The cross-sectional descriptive study was carried out on the 
retrospective data of all patented drugs used at Nguyen-Dinh-Chieu 
Hospital in Ben-Tre Province from 2011 to 2017. Criteria for selecting 
the subjects were as follows: be in the drugs list of the hospital from 
2011 to 2017, and be in the 18 lists issued by the Health Ministry 
about patented drugs used in hospitals from 2013 to 2017.  
Descriptive criteria 
The characteristics of drugs utilization were described by frequency 
and percentage of drugs quantities and costs. Criteria for the 
description were as follows: active ingredient, route of administration, 
therapeutic class (classified according to the circular No. 40/2014/TT-
BYT) and manufacturing country. The characteristics related to the 
registration for circulation of patented drugs in Vietnam were also 
introduced in this study. 
RESULTS 
The general characteristics of patented drugs utilized 
During the 7-year period, Nguyen-Dinh-Chieu Hospital utilized a 
total of 212 patented drugs, relating to 145 different active 
ingredients. Single ingredient drugs accounted for 88.0% of the total 
number of patented drugs and 87.5% of the total spending on 
patented drugs. The proportion of the spending on injectable drugs 
was twice as high as the proportion for oral drugs (59.5% vs 28.1%). 
Patented drugs were classified in 20 therapeutic classes, in which 
antimicrobial and cardiovascular drugs represented the highest 
proportions both in the number of drugs and the spending on drugs. 
79% of patented drugs were manufactured by pharmaceutical 
companies in Europe and the majority came from Germany (39 
drugs) and France (38 drugs). 70.3% of patented drugs had been 
registered for the first time during the period of study (fig. 1). 
The patented drugs utilization 
The spending on patented drugs increased by 18% from 2011 to 2015 
fig. 2. Regarding routes of administration, the ratios of patented drugs 
used were stable. Regarding therapeutic classes and manufacturing 
companies, those ratios fluctuated during the 2011-2017 period. table 1 
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Fig. 1: The general characteristics of patented drugs utilized at NDCBT in the period of 2011-2017 
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Table 1: Description of characteristics of patented drugs utilized at NDCBT in the period of 2011-2017 
Year Number of patented drugs Ratio of spending on patented drugs 
2011 2012 2013 2014 2015 2016 2017 2011-
2017 



























































20.0 18.8 11.8 8.4 11.7 12.5 21.2 14.8 

































3.6 11.8 12.6 14.5 10.5 11.8 10.0 11.1 
















36.7 37.9 41.4 40.5 45.8 49.3 48.2 45.2 
Route of administration 
















34.8 30.1 33.4 21.8 24.3 27.5 31.2 28.1 
















56.8 60.9 53.7 66.2 64.2 58.7 55.7 59.5 

















































































































1.4 7.3 8.7 1.0 10.2 7.9 17.7 9.7 
















25.4 38.4 34.8 32.8 32.5 38.9 39.9 36.2 
 
 
Fig. 2: The trends in the utilization of 212 patented drugs compared to all drugs at NDCBT in the period of 2011-2017 
 
DISCUSSION 
The study described the main characteristics of the utilization of 212 
patented drugs used at Nguyen-Dinh-Chieu Hospital in the period of 
2011-2017. Compared to the characteristics of disease patterns in 
the hospital during the same period, the study discovered a 
difference between the most common type of patented drugs 
utilized and the most common reasons for inpatient visits (which are 
respiratory diseases with the incidence of 14.0%) [7]. These results 
suggest that there might be a correlation between the prescription of 
patented drugs and the medical conditions of patients. Particularly, 
patented drugs might be prioritized to use if patients were in the 
first stage of a treatment therapy or patients were in severe clinal 
conditions. In cases that patients’ clinical conditions were 
improving, physicians might consider switching to lower-cost and 
bioequivalent generic alternatives. The utilization of patented drugs 
was illustrated according to the number of drug types and the 
annual spending with fluctuations recognized after comparing with 
different therapeutic classes or different manufacturing countries. 
These characteristics were consistent with other characteristics 
recorded from previous studies [8-9]. In 2017, the spending on 
patented drugs at Nguyen-Dinh-Chieu Hospital accounted for 29.3% 
of the total spending on drugs. This proportion was higher than the 
recommended proportion of spending on patented drugs for the first 
level hospital according to the agreement between the Health 
Ministry and the Vietnam Social Security [5]. Consequently, it is 
necessary to take measures to reduce the spending on patented 
drugs at the hospital in the next period. 
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This is the first study that investigated the characteristics of 
patented drugs utilization at a certain hospital over a long period of 
time. With full and diverse data, the patented drugs utilization at 
Nguyen-Dinh-Chieu Hospital was described according to many 
criteria, from which many important pieces of information were 
revealed. This study is the foundation for future studies to develop a 
full picture of patented drugs utilization. 
LIMITATIONS 
A patented drug was defined in this study based on the patented 
drug definition specified in the Circular No. 11/2016/TT-BYT of the 
Vietnamese Ministry of Health [10]. This definition was not 
completely consistent with the definition in the pharmaceutical 
manufacture field, thus, there were limitations in comparing and 
discussing the results of this study with literature.  
CONCLUSION 
The study showed trends in utilizing patented drugs year by year at 
Nguyen-Dinh-Chieu Hospital. It is the reference study which other 
hospitals will be able to apply to optimize the structure of the drugs 
list, from which the balance of therapeutic efficacy and affordability 
for drugs of local communities will be obtained. 
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